摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N6-[6-[3,5-di-tert-butyl-4-hydroxybenzamido]hexyl]adenosine

中文名称
——
中文别名
——
英文名称
N6-[6-[3,5-di-tert-butyl-4-hydroxybenzamido]hexyl]adenosine
英文别名
3,5-di-tert-butyl-N-(6-(9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-9H-purin-6-ylamino)hexyl)-4-hydroxybenzamide;3,5-ditert-butyl-N-[6-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]hexyl]-4-hydroxybenzamide
N<sup>6</sup>-[6-[3,5-di-tert-butyl-4-hydroxybenzamido]hexyl]adenosine化学式
CAS
——
化学式
C31H46N6O6
mdl
——
分子量
598.743
InChiKey
WILCPLUIPOFNDM-VKUKUQHZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    43
  • 可旋转键数:
    13
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    175
  • 氢给体数:
    6
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3,5-二叔丁基-4-羟基苯甲酸N6-(6-Aminohexyl)adenosine1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以72%的产率得到N6-[6-[3,5-di-tert-butyl-4-hydroxybenzamido]hexyl]adenosine
    参考文献:
    名称:
    Dual acting antioxidant A1 adenosine receptor agonists
    摘要:
    Herein we report the synthesis and biological evaluation of some potent and selective A, adenosine receptor agonists, which incorporate a functionalised linker attached to an antioxidant moiety. N-6-(2,2,5,5-Tetramethylpyrrolidin-1-yloxyl-3-ylmethyl)-adenosine (VCP28, 2e) proved to be an agonist with high affinity (K-i = 50 nM) and good selectivity (A(3)/A(1) >= 400) for the A, adenosine receptor. N-6-[4-[2-[1,1,3,3-Tetramethylisoindolin-2-yloxyl-5-amido]ethyl]phenyl]adenosine (VCP102, 5a) has higher binding affinity (Ki = 7 nM), but lower selectivity (A(3)/A(1) = similar to 3). All compounds bind weakly (K-i > 1 mu M) to A(2A) and A(2B) receptors. The combination of-A, agonist activity and antioxidant activity has the potential to produce cardioprotective effects. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.07.035
点击查看最新优质反应信息

文献信息

  • Dual acting antioxidant A1 adenosine receptor agonists
    作者:Alison Gregg、Steven E. Bottle、Shane M. Devine、Heidi Figler、Joel Linden、Paul White、Colin W. Pouton、Vijay Urmaliya、Peter J. Scammells
    DOI:10.1016/j.bmcl.2007.07.035
    日期:2007.10
    Herein we report the synthesis and biological evaluation of some potent and selective A, adenosine receptor agonists, which incorporate a functionalised linker attached to an antioxidant moiety. N-6-(2,2,5,5-Tetramethylpyrrolidin-1-yloxyl-3-ylmethyl)-adenosine (VCP28, 2e) proved to be an agonist with high affinity (K-i = 50 nM) and good selectivity (A(3)/A(1) >= 400) for the A, adenosine receptor. N-6-[4-[2-[1,1,3,3-Tetramethylisoindolin-2-yloxyl-5-amido]ethyl]phenyl]adenosine (VCP102, 5a) has higher binding affinity (Ki = 7 nM), but lower selectivity (A(3)/A(1) = similar to 3). All compounds bind weakly (K-i > 1 mu M) to A(2A) and A(2B) receptors. The combination of-A, agonist activity and antioxidant activity has the potential to produce cardioprotective effects. (C) 2007 Elsevier Ltd. All rights reserved.
查看更多